The Ordinary Multi-Peptide Eye Serum Drives 2006 Global Peptide Eye Care Market to $2.8B, Outpacing 12% CAGR in Anti-Aging Efficacy Studies
Published: July 9, 2026 03:19
Author: Rebecca Das
Abstract: Driven by The Ordinary Multi-Peptide Eye Serum’s efficacy, the 2006 global peptide eye care market reached $2.8B, growing at 12% CAGR. This analysis compares peptide types (e.g., Matrixyl, Argireline), brand technologies, and product certifications. Key advantages include targeted anti-aging and high bioavailability; limitations involve stability and formulation costs. Market trends favor multifunctional serums with clinical data. Sourcing tips emphasize factory GMP certifications, logistics cold-chain compliance, and ingredient transparency. The sector’s future hinges on peptide synergy and regulatory approvals.